Brain injury drug may tame inflammation after surgery
NCT ID NCT07406555
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the sedative dexmedetomidine can lower C-reactive protein (CRP), a marker of inflammation, in 25 adults with traumatic brain injury undergoing emergency or planned skull surgery. Patients received either dexmedetomidine or a standard sedative during surgery. The goal was to see if dexmedetomidine could dampen the body's inflammatory response after the operation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dexmedetomidine
- What this could lead to
- If it works, this could point toward using dexmedetomidine to reduce harmful inflammation after brain surgery, potentially improving recovery.
- What could go wrong
- This is a very small, single-hospital study (25 people) looking only at a blood marker, not patient outcomes. Results may not apply broadly or lead to a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RSUD Prof. Dr. Margono Soekarjo
Purwokerto, Central Java, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Could music be medicine for the injured brain?
- Can blood markers predict brain injury outcomes?
- Can a treadmill that adapts to your pace fix uneven steps?
- Can brain training help TBI patients remember to remember?
- Can a natural protein fragment help the brain heal after severe injury?